A nomogram model for predicting the risk of checkpoint inhibitor‐related pneumonitis for patients with advanced non‐small‐cell lung cancer

OBJECTIVE: Immunotherapy extensively treats advanced non‐small‐cell lung cancer (NSCLC). Although immunotherapy is generally better tolerated than chemotherapy, it can cause multiple immune‐related adverse events (irAEs) involving multiple organs. Checkpoint inhibitor‐related pneumonitis (CIP) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yao, Zhang, Lincheng, Cao, Shuhui, Wang, Yue, Ling, Xuxinyi, Zhou, Yan, Zhong, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469710/
https://www.ncbi.nlm.nih.gov/pubmed/37409360
http://dx.doi.org/10.1002/cam4.6244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469710/
https://www.ncbi.nlm.nih.gov/pubmed/37409360
http://dx.doi.org/10.1002/cam4.6244

Ejemplares similares